CA-125 alone is widely used to diagnose progressive disease (PD) in platinum-sensitive recurrent ovarian cancer (PSROC) on chemotherapy.
4 miesiące temu

Matulonis: Based on this pooled analysis, patients with PSROC on a PARPi should continue CA-125 testing, but clinicians should also incorporate...
2 miesiące temu

Current treatment guidelines recommend using cancer antigen-125 (CA-125) as a diagnostic marker for ovarian cancer recurrence,...
miesiąc temu

Dr Smith on the Rationale for Investigating the Predictive Utility of CA-125 KELIM Score in Ovarian Cancer · Prophylactic Itacitinib May Safely...
2 miesiące temu

The biomarker CA125 for early detection of ovarian cancer.
3 miesiące temu

A recent study in the British Journal of Cancer has identified promising biomarkers that complement CA125 in the early detection of ovarian...
3 miesiące temu

In testing diagnostic ability, the study finds an overall 88% accuracy with their seven-marker method compared to 79% with the existing CA125...
10 miesięcy temu

Congestion Biomarker CA125 Signals Worse Outcomes in Ambulatory HFrEF · The results suggest CA125 could be complementary to NT-proBNP, but it's...
9 miesięcy temu

Polymer materials with hydrophilic and electrically neutral were synthesized by a simple reaction. •. Polyaniline enhances electrochemical...
9 miesięcy temu

Recurrent epithelial ovarian carcinoma is considered an incurable disease, and second-line chemotherapy is mainly considered for palliation...
2 miesiące temu